Harmony Biosciences Holdings, Inc. HRMY Business Segments — Segment Reporting Other Item Amount

Similar metrics at other companies

OPENReportable Segment — Segment Reporting, Other Segment Item, Amount

$8M-52.9%

AVBPSingle Reportable — Segment Reporting Other Item Amount

-$2.79M-17.0%

THGSpecialty Lines — Segment Reporting Other Item Amount

$2M-9.1%

MDTNeuroscience — Other segment items

$13M+8.3%

AAPReportable — Segment Reporting Other Item Amount

-$31M-14.8%

OMCLReportable Segment — Segment Reporting, Other Segment Item, Amount

$14.3M-31.7%

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s business segments — segment reporting other item amount?

Harmony Biosciences Holdings, Inc. (HRMY) reported business segments — segment reporting other item amount of $32.13M in Q1 2026.

How has Harmony Biosciences Holdings, Inc.'s business segments — segment reporting other item amount changed year-over-year?

Harmony Biosciences Holdings, Inc.'s business segments — segment reporting other item amount increased by 11540.2% year-over-year, from $276K to $32.13M.

What is the long-term trend for Harmony Biosciences Holdings, Inc.'s business segments — segment reporting other item amount?

Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s business segments — segment reporting other item amount has grown at a 5.4% compound annual growth rate (CAGR), from $29.83M to $34.93M.

What does business segments — segment reporting other item amount mean?

This metric represents miscellaneous income or expense items specifically allocated to the rare neurological diseases business segment that do not fit into standard operating categories. It captures non-recurring or unique financial adjustments that impact the segment's profitability. Analysts use this to identify one-time events or specific accounting adjustments that may distort underlying operational performance.